Breaking News on Global Pharmaceutical Technology & Manufacturing

Headlines > November 2004

« Previous month Next month »

BioPartners files for 'biosimilar' hGH

30-Nov-2004 - Switzerland-based BioPartners has submitted a second Marketing Authorisation Application in Europe for a generic copy of a biologic drug under the recently agreed European Union framework for so-called 'biosimilar' drugs.

Ultrapure water unit from Christ Water

30-Nov-2004 - Germany's Christ Water Technology has developed a ready-to-connect water filtration plant that is specifically designed for use in the pharmaceutical, chemical and cosmetics industries.

Pharming raises €6m for new projects

30-Nov-2004 - Pharming of the Netherlands, which is pioneering the use of transgenic animals for the production of biologics, has raised €6 million from a placing of shares and will use the...

NJP buys into flexible pharma packaging

30-Nov-2004 - In the US, New Jersey Packaging has acquired Altwood Roll Label, which supplies flexible packaging, inserts and labels to the pharmaceutical and healthcare sector.

Flint announces packaging ink price increase

29-Nov-2004 - Flint Ink North America has announced a price increase for packaging ink products ranging from 5 to 7 per cent depending on ink type. The increase, effective 1 December 2004,...

Gene therapy shows promise in Parkinson's disease

29-Nov-2004 - Research that could eventually lead to gene therapy treatment options for patients with Parkinson's disease has been published this week, which could bring hope to more than 1 million Americans...

Long chain amyloid a drug target?

29-Nov-2004 - Scientists have identified a new, longer species of the amyloid b-peptide that has the potential to be a new target for the treatment of Alzheimer's disease The discovery serves as...

Avecia sells off nitroglycerin business

29-Nov-2004 - Manchester, UK-based Avecia has sold off its Special Drug Mixtures subsidiary to Copperhead Chemical of the US.

Merck exits another French production site

29-Nov-2004 - German chemical and pharmaceutical company Merck KGaA has sold off a manufacturing facility in France in a move aimed at consolidating its global production infrastructure.

Packaging film prices on the rise

29-Nov-2004 - The UK Packaging and Industrial Films Association (PIFA) is warning buyers of plastic film products to expect further price increases as producers and converters are forced to look for recovery...

Slow growth for Euro API suppliers forecast

29-Nov-2004 - Overcapacity remains the main issue affecting the European market for active pharmaceutical ingredients, with lack of capability differentiation and competition from low-cost manufacturers also holding back growth in the sector.

Peptide synthesis made simple with new enzyme

29-Nov-2004 - Japan's Ajinomoto has developed a revolutionary enzymatic method to manufacture peptides that could dramatically cut the cost of producing this growing class of therapeutic agents.

Artificial liver an alternative to toxicity testing

26-Nov-2004 - Bioengineers at the University of Oxford have developed a solution to the problem of toxicity testing for new drugs, which can prove to be ineffective or at worst dangerous to...

BASF trims down at Ludwigshafen

25-Nov-2004 - German chemical giant BASF is to shed about 3,600 jobs at its main Ludwigshafen plant over the next three years as part of efforts ensure the site's competitiveness.

Consortium AIMs to cut MAb production costs

25-Nov-2004 - The European Commission has launched an €11.4 million project to identify ways of improving the production of biologic drugs and cutting the cost of treatment.

Wyatt Technology buys Dynapro manufacturer

25-Nov-2004 - Wyatt Technology, a specialist in macromolecular characterisation instrumentation and software, has completed the acquisition of Proterion Corp, a US firm making dynamic light scattering instruments.

New drug extends multiple sclerosis options

25-Nov-2004 - The first in a completely new class of drug for multiple sclerosis has been approved in the US, opening up a new avenue of treatment for sufferers of the debilitating...

UK academic turns to AFRICA for process development

25-Nov-2004 - After a successful trial period, Syrris has supplied one of its recently-launched AFRICA microreactor systems to Professor Steven Ley at the Department of Chemistry at the University of Cambridge, UK....

Cambridge film assessed by BioProgress

24-Nov-2004 - BioProgress has signed an agreement with Cambridge University Technical Services Ltd giving it an exclusive eight month option to evaluate new film technology developed at the UK university, writes Phil...

Patheon buys Puerto Rican rival

24-Nov-2004 - Contract pharmaceutical manufacturer Patheon is to buy Puerto Rican rival Mova Pharmaceuticals in a transaction that could be valued as high as $350 million in cash, stock and assumed debt.

Charles River to back genOway's animal models

24-Nov-2004 - Charles River Laboratories of the US and France's genOway have formed a collaboration to market genetically modified research models to research customers in Europe.

New client for BioPharm-Alliance

24-Nov-2004 - Parexel and Sartorius have been awarded a contract to supply, validate and help operate a biologic manufacturing facility in South Korea, said to be the first of its kind in...

DSM buys stake in Chinese pharma group

24-Nov-2004 - Dutch chemicals and ingredients company DSM is to purchase a stake in North China Pharmaceutical Group in a move that boosts its presence in the country, writes Phil Taylor.

Automated HT crystallography transforms drug discovery

24-Nov-2004 - High throughput protein (HTP) crystallography is set to undergo key technical developments in which the development of automation in protein expression, protein engineering and crystallisation will provide the accurate screening...

« Previous month Next month »

Key Industry Events


Access all events listing

Our events, Shows & Conferences...